Pericyte loss accelerates development of Alzheimer’s disease pathology including amyloid beta (Aβ) deposition, tau pathology, and neuronal loss (Sagare et al., 2013). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.